Drug Trials News for December 2020

MHRA approval for nasal COVID-19 vaccine clinical trial

First in human trials for vaccine candidate with the potential to confer long-term immunity
22 December, 2020

HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

Results support first proof of concept for HOOKIPA’s replicating investigational single-vector immunotherapy in oncology. Data demonstrate responses and stable disease in some head and neck cancer patients who all received at least two prior therapies and progressed on a PD1 inhibitor. By targeting an antigen common to Human Papillomavirus 16-positive (HPV16+), HB-201 has the potential to be a tumor-agnostic therapy for all HPV16+ cancers
07 December, 2020

Drug Trials News Archive

MHRA approval for nasal COVID-19 vaccine clinical trial MHRA approval for nasal COVID-19 vaccine clinical trial

MHRA approval for nasal COVID-19 vaccine clinical trial